相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature
Nahid Reisi et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis
Justin Ferrell et al.
PEDIATRIC BLOOD & CANCER (2021)
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis
Gaurav Goyal et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Histiocytic Neoplasms, Version 2.2021
Ronald S. Go et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Radiologic findings that aid in the reduction of misdiagnoses of Langerhans cell histiocytosis of the bone: a retrospective study
Mimi Zhao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Clinical features and treatment of Langerhans cell histiocytosis
Carlos Rodriguez-Galindo
ACTA PAEDIATRICA (2021)
Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review
Antoine Neel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Efficacy ofBRAF-InhibitorTherapy in BRAFV600E-MutatedAdult Langerhans Cell Histiocytosis
Antonious Z. Hazim et al.
ONCOLOGIST (2020)
Langerhans cell histiocytosis withBRAFp.N486_P490del orMAP2K1p.K57_G61del treated by the MEK inhibitor trametinib
Yoav H. Messinger et al.
PEDIATRIC BLOOD & CANCER (2020)
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Eli L. Diamond et al.
NATURE (2019)
BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis
Erdener Ozer et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2019)
Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosis
Yempabou Sagna et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans Cell Histiocytosis
Jeong Rye Kim et al.
SCIENTIFIC REPORTS (2019)
Diagnosis and treatment of Langerhans Cell Histiocytosis with bone lesion in pediatric patient: A case report
Achmad Fauzi Kamal et al.
ANNALS OF MEDICINE AND SURGERY (2019)
Langerhans cell histiocytosis in an adult with oral cavity involvement: Posing a diagnostic challenge
Richa Nangalia et al.
CONTEMPORARY CLINICAL DENTISTRY (2019)
Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis
L. Montefusco et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations
Gary Tran et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Bone metabolism in Langerhans cell histiocytosis
Athanasios D. Anastasilakis et al.
ENDOCRINE CONNECTIONS (2018)
Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment
Masayuki Kobayashi et al.
CANCER SCIENCE (2018)
Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition
Gil Awada et al.
BLOOD ADVANCES (2018)
Periostin: The bone and beyond
L. Idolazzi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity
Athanasios D. Anastasilakis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Denosumab for the treatment of adult multisystem Langerhans cell histiocytosis
Polyzois Makras et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study
Abdellatif Tazi et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Periostin action in bone
Nicolas Bonnet et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series
Deepak Chellapandian et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2016)
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
Jean Donadieu et al.
BLOOD (2015)
Nosology and Pathology of Langerhans Cell Histiocytosis
Jennifer Picarsic et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Rationale for the Application of RANKL Inhibition in the Treatment of Langerhans Cell Histiocytosis
Polyzois Makras et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Noah A. Brown et al.
BLOOD (2014)
Recent advances in Langerhans cell histiocytosis
Akira Morimoto et al.
PEDIATRICS INTERNATIONAL (2014)
More than Just Langerhans Cell Histiocytosis: A Radiologic Review of Histiocytic Disorders
Jatin Zaveri et al.
RADIOGRAPHICS (2014)
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net
Michael Girschikofsky et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease
Jan Kriz et al.
RADIATION ONCOLOGY (2013)
Serum Osteoprotegerin, RANKL, and Dkk-1 Levels in Adults with Langerhans Cell Histiocytosis
Polyzois Makras et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Reduced bone mineral density in adult patients with Langerhans cell histiocytosis
Polyzois Makras et al.
PEDIATRIC BLOOD & CANCER (2012)
Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions
Maria A. Cantu et al.
PLOS ONE (2012)
Langerhans cells down-regulate inflammation-driven alveolar bone loss
Moran Arizon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Skeletal Diseases in Cushing's Syndrome: Osteoporosis versus Arthropathy
Gregory Kaltsas et al.
NEUROENDOCRINOLOGY (2010)
Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects
Cory J. Xian et al.
BONE (2007)
Endocrine manifestations in Langerhans cell histiocytosis
Polyzois Makras et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Cutaneous langerhans cell sarcoma:: A case report and review of the literature
Olga L. Bohn et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells
Mawadda Alnaeeli et al.
JOURNAL OF IMMUNOLOGY (2006)
High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in langerhans cell histiocytosis
Rumiko Ishii et al.
PEDIATRIC BLOOD & CANCER (2006)
Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH)
P Makras et al.
NEURORADIOLOGY (2006)